Keytruda improves survival in late-stage trial of cHL

FDA approved Keytruda to treat refractory cHL in March 2017. Credit: Merck Sharp & Dohme Corp.



  • FDA approved Keytruda to treat refractory cHL in March 2017. Credit: Merck Sharp & Dohme Corp.